<html>
<head>PUBMED IDs for SPAN-Xb</head>
<body bgcolor='#C5F0F2'><h1>SPAN-Xb</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12393489/'>Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies.</a> October 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14595213/'>Pattern of gene expression and immune responses to Semenogelin 1 in chronic hematologic malignancies.</a> November 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14595196/'>Response to Pan et al., microarray gene analysis and expression profiles of Dupuytren's contracture.</a> November 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14595131/'>Which US microbubble contrast agent is best for gene therapy?</a> November 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16187275/'>SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically.</a> September 28  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17036333/'>SPAN-XB core promoter sequence is regulated in myeloma cells by specific CpG dinucleotides associated with the MeCP2 protein.</a> October 13  2006<br></body></html>
